Skip to main content
MBX logo

MBX · MBX Biosciences, Inc. · Investor Relations

Track MBX — free
$53.12 -2.82 (-5.04%) At close · Nov 16 Play latest call Q2 2025 earnings call transcript
Market Cap
$2.64B
Shares
49.66M
Volume · Nov 16 391.31K Avg daily vol (3M) 525.58K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-17 08:30 UTC UBS Global Biopharma Conference Conference
2026-11-18 16:25 UTC Jefferies Global Healthcare Conference Conference

Recent news

Past events

Date Event Type
2026-11-10 Guggenheim 3rd Annual Healthcare Innovation Conference Conference
2026-09-30 Stifel 2026 Virtual Cardiometabolic Forum Webcast
2026-09-16 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-06-12 MBX Virtual Investor Event: Once-Weekly Canvuparatide Presentations at ENDO 2026 Event
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-11 MBX In-person and Virtual Obesity Day Webcast
2026-03-11 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-11 2026 Jefferies Biotech on the Beach Summit Event
2026-03-10 The Citizens Life Sciences Conference Conference
2026-03-10 UBS Biotech Summit Miami – Catalyst for Change Event
2026-03-02 TD Cowen's 46th Annual Health Care Conference Conference
2026-02-25 Oppenheimer 36th Annual Healthcare Life Sciences Conference Conference
2026-01-13 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-02 Piper Sandler 37th Annual Healthcare Conference Conference
2025-11-24 TD Cowen Treatment Advancements in Obesity and Related Disorders Summit Webcast
2025-11-19 Jefferies Global Healthcare Conference in London Conference
2025-11-12 Stifel Healthcare Conference Conference
2025-11-10 Guggenheim 2nd Annual Healthcare Innovation Conference Conference
2025-09-30 Stifel 2025 Virtual Cardiometabolic Forum Webcast
2025-09-22 MBX Biosciences Conference Call - Topline Results from Avail Phase 2 Trial Earnings call
2025-06-09 Goldman Sachs 46th Annual Global Healthcare Conference Conference
2025-06-04 Jefferies Global Healthcare Conference Conference
2025-05-21 RBC 2025 Global Healthcare Conference Conference
2025-05-07 The Citizens Life Sciences Conference Conference
2025-04-07 24th Annual Needham Virtual Healthcare Conference Conference

Source: https://mbxbio.com/investors/

Key facts CIK 1776111 CUSIP 55287L101 13F (30d) 150 filings 145 filers Visit website Investor relations